To corroborate the findings, we measured ebv-miR-BART7 and GFPT1 transcript level in primary NPC tissues (prior treatment) and normal nasopharyngeal epithelia (Figure 1C). The gene discussed is GFPT1; the disease is nasopharyngeal carcinoma.